Margaret Foti: Devoted to cancer research
Entrepreneurs Boldly Break New Ground
Mark Tykocinski: Open doors lead a scientist to his calling
Shire Pharmaceuticals: A Study in Exponential Growth
Cephalon, the leading independent biotechnology firm in Pennsylvania and the Greater Philadelphia region, has seen its fair share of rocky times in the last two decades. However, as the $5 billion market cap company celebrates its 20th anniversary, it stands in a far better position than it has ever been.
"Over the last 20 years we have used our keen eye for identifying opportunities, our research ingenuity, and sheer perseverance to grow from a startup biotech company to one of the top ten biotech companies in the world," says Frank Baldino, Jr., chairperson and CEO of Cephalon.
Baldino grew up in the Greater Philadelphia area; he graduated from a high school in ...
